BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 26305715)

  • 21. Synergistic effect of cyanidin and PPAR agonist against nonalcoholic steatohepatitis-mediated oxidative stress-induced cytotoxicity through MAPK and Nrf2 transduction pathways.
    Shih PH; Hwang SL; Yeh CT; Yen GC
    J Agric Food Chem; 2012 Mar; 60(11):2924-33. PubMed ID: 22364184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liver-specific Nrf2 deficiency accelerates ethanol-induced lethality and hepatic injury in vivo.
    Sun J; Hong Z; Shao S; Li L; Yang B; Hou Y; Wang H; Xu Y; Zhang Q; Pi J; Fu J
    Toxicol Appl Pharmacol; 2021 Sep; 426():115617. PubMed ID: 34116071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Yangonin inhibits ethanol-induced hepatocyte senescence via miR-194/FXR axis.
    Dong R; Wang X; Wang L; Wang C; Huang K; Fu T; Liu K; Wu J; Sun H; Meng Q
    Eur J Pharmacol; 2021 Jan; 890():173653. PubMed ID: 33068587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
    Rogue A; Anthérieu S; Vluggens A; Umbdenstock T; Claude N; de la Moureyre-Spire C; Weaver RJ; Guillouzo A
    Toxicol Appl Pharmacol; 2014 Apr; 276(1):73-81. PubMed ID: 24534255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice.
    Wang Z; Dou X; Li S; Zhang X; Sun X; Zhou Z; Song Z
    Hepatology; 2014 Apr; 59(4):1381-92. PubMed ID: 24170703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obeticholic Acid Ameliorates Valproic Acid-Induced Hepatic Steatosis and Oxidative Stress.
    Gai Z; Krajnc E; Samodelov SL; Visentin M; Kullak-Ublick GA
    Mol Pharmacol; 2020 May; 97(5):314-323. PubMed ID: 32098797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quercetin mitigates ethanol-induced hepatic steatosis in zebrafish via P2X7R-mediated PI3K/ Keap1/Nrf2 signaling pathway.
    Zhao X; Gong L; Wang C; Liu M; Hu N; Dai X; Peng C; Li Y
    J Ethnopharmacol; 2021 Mar; 268():113569. PubMed ID: 33186701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes.
    Kang OH; Kim SB; Mun SH; Seo YS; Hwang HC; Lee YM; Lee HS; Kang DG; Kwon DY
    Int J Mol Med; 2015 Mar; 35(3):803-9. PubMed ID: 25605057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FXR deletion in hepatocytes does not affect the severity of alcoholic liver disease in mice.
    Zhang M; Kong B; Huang M; Wan R; Armstrong LE; Schumacher JD; Rizzolo D; Chow MD; Lee YH; Guo GL
    Dig Liver Dis; 2018 Oct; 50(10):1068-1075. PubMed ID: 29730159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
    Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
    Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dihydroartemisinin protects against alcoholic liver injury through alleviating hepatocyte steatosis in a farnesoid X receptor-dependent manner.
    Xu W; Lu C; Yao L; Zhang F; Shao J; Zheng S
    Toxicol Appl Pharmacol; 2017 Jan; 315():23-34. PubMed ID: 27939985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dihydrocurcumin ameliorates the lipid accumulation, oxidative stress and insulin resistance in oleic acid-induced L02 and HepG2 cells.
    Yu Q; Liu Y; Wu Y; Chen Y
    Biomed Pharmacother; 2018 Jul; 103():1327-1336. PubMed ID: 29864915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective Effect of Glycyrrhizic Acid on Alcoholic Liver Injury in Rats by Modulating Lipid Metabolism.
    Huo X; Yang S; Sun X; Meng X; Zhao Y
    Molecules; 2018 Jul; 23(7):. PubMed ID: 29973492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gentiopicroside Ameliorates Oxidative Stress and Lipid Accumulation through Nuclear Factor Erythroid 2-Related Factor 2 Activation.
    Jin M; Feng H; Wang Y; Yan S; Shen B; Li Z; Qin H; Wang Q; Li J; Liu G
    Oxid Med Cell Longev; 2020; 2020():2940746. PubMed ID: 32655764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells.
    Vecchione G; Grasselli E; Voci A; Baldini F; Grattagliano I; Wang DQ; Portincasa P; Vergani L
    World J Gastroenterol; 2016 Jul; 22(26):6016-26. PubMed ID: 27468193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Farnesoid X Receptor Activation on Arachidonic Acid Metabolism, NF-kB Signaling, and Hepatic Inflammation.
    Gai Z; Visentin M; Gui T; Zhao L; Thasler WE; Häusler S; Hartling I; Cremonesi A; Hiller C; Kullak-Ublick GA
    Mol Pharmacol; 2018 Aug; 94(2):802-811. PubMed ID: 29743187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Baicalin Attenuates Alcoholic Liver Injury through Modulation of Hepatic Oxidative Stress, Inflammation and Sonic Hedgehog Pathway in Rats.
    Wang H; Zhang Y; Bai R; Wang M; Du S
    Cell Physiol Biochem; 2016; 39(3):1129-40. PubMed ID: 27576501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of insulin pre-administration in mice exposed to ethanol: alleviating hepatic oxidative injury through anti-oxidative, anti-apoptotic activities and deteriorating hepatic steatosis through SRBEP-1c activation.
    Liu J; Wang X; Peng Z; Zhang T; Wu H; Yu W; Kong D; Liu Y; Bai H; Liu R; Zhang X; Hai C
    Int J Biol Sci; 2015; 11(5):569-86. PubMed ID: 25892964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered ethanol metabolism and increased oxidative stress enhance alcohol-associated liver injury in farnesoid X receptor-deficient mice.
    Morel C; Chowdhary V; Thevkar Nagesh P; Ribeiro M; Hawryluk D; Catalano D; Adorini L; Szabo G
    Liver Int; 2023 Jan; 43(1):100-114. PubMed ID: 35869657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
    Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
    J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.